With the threat of a flu pandemic looming, researchers are racing to develop tools to help diagnose and identify new flu strains quickly. A portable lab-on-a-chip called the Genotyper, developed by a multidisciplinary team at the University of Michigan, could eventually allow doctors to de-code the genetic makeup of flu viruses in less than two hours.
Ultimately, the Genotyper will be fully portable and could even be connected wirelessly, thus able to track the spread of existing or emerging flu strains around the globe, said Ron Larson, U-M chemical engineering professor and part of the team developing the technology.
The technology originated in the laboratories of Mark Burns and David Burke, engineering professors who sought to develop fast, inexpensive methods for deriving genetic information from humans, and is now being applied to genotyping influenza virus by a team that also includes Larson, and professors Michael Solomon and Oveta Fuller.
The process for identifying the flu type is similar to genetic fingerprinting used in DNA identification. First, the influenza RNA is converted to DNA, using the same biological processes that the HIV virus uses to convert RNA to DNA to replicate itself and elude the immune system. Then, a segment of the DNA is reproduced in a process called PCR, or "polymerase chain reaction," and enzymes are released that "digest," or cut that DNA at certain points.
"The way the gene is cut or not cut depends on which flu gene you have," Larson said. "Once the genes are cut, you can separate them based on size in a gel." The pattern of fragment sizes tells you the locations of the cuts in the DNA, and this provides a "fingerprint" that distinguishes the type of flu.
During that process, the DNA fragments are run though a gel, which, when it is electrically charged, causes the DNA fragments to move at certain speeds depending on size. The short fragments squirt through quickly, the longer ones more slowly, Larson said. The fragments are stained with fluorescent tags, which allow scientists to distinguish one flu strain from the next, or tell if a new strain has emerged.
Different types of DNA strands can be tested and identified using the same device by simply using different reagents. To demonstrate the Genotyper's versatility, researchers did tests on DNA from a human, a mouse, and from a strain of influenza. The entire device would be about as big as a television remote control, Larson said.
The findings are outlined in a paper, Microfluidic Integrated Device for Genetic Analysis, written by an interdisciplinary team whose primary authors include Larson, Burns, Burke, and Fuller.
Source: University of Michigan College of Engineering
CDC Urges Vigilance: New Recommendations for Monitoring and Testing H5N1 Exposures
July 11th 2025With avian influenza A(H5N1) infections surfacing in both animals and humans, the CDC has issued updated guidance calling for aggressive monitoring and targeted testing to contain the virus and protect public health.
IP LifeLine: Layoffs and the Evolving Job Market Landscape for Infection Preventionists
July 11th 2025Infection preventionists, once hailed as indispensable during the pandemic, now face a sobering reality: budget pressures, hiring freezes, and layoffs are reshaping the field, leaving many IPs worried about their future and questioning their value within health care organizations.
A Helping Hand: Innovative Approaches to Expanding Hand Hygiene Programs in Acute Care Settings
July 9th 2025Who knew candy, UV lights, and a college kid in scrubs could double hand hygiene adherence? A Pennsylvania hospital’s creative shake-up of its infection prevention program shows that sometimes it takes more than soap to get hands clean—and keep them that way.